Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$7.89 - $13.14 $26,210 - $43,651
-3,322 Reduced 11.1%
26,605 $339,000
Q3 2023

Nov 09, 2023

SELL
$9.88 - $14.0 $839 - $1,190
-85 Reduced 0.28%
29,927 $309,000
Q2 2023

Aug 09, 2023

BUY
$10.78 - $13.65 $323,529 - $409,663
30,012 New
30,012 $393,000
Q3 2022

Nov 09, 2022

BUY
$15.35 - $23.99 $288,702 - $451,203
18,808 New
18,808 $313,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Group One Trading, L.P. Portfolio

Follow Group One Trading, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.